비피도
238200KOSDAQ56.4 / 100
Reference Date: 2026-09-08
Company InformationBased on 2025 Annual Report
Business Overview
Bifido is a company that produces probiotic raw materials and finished products based on physiologically active bifidobacteria strains discovered by Professor Ji Geun-eok in 1994. It holds FDA NDI and GRAS certifications and utilizes the MAP platform technology to develop functional probiotics and microbiome-based therapeutics. The company is also expanding into B2C markets through the development of individually recognized probiotic raw materials.
Number of Employees
102people
Average Salary
42.5M KRW
Score Calculation Basis
Detailed Financial Score
Half of industry avg (excellent)
Well below industry avg
Half of industry avg (excellent)
Avg ▲12.8% (2-year basis)
Avg ▼537.9% (2-year basis)
Avg ROE -3.1% (declining, 3yr)
Detailed News Sentiment
- Neutral일동바이오사이언스, '비타푸드 아시아' 참가...기능성 프로바이오틱.....
일동바이오사이언스의 글로벌 박람회 참가 소식은 회사의 국제적 노출을 높이지만, 비피도 주식에 직접적인 영향은 제한적입니다.
- Positive일동바이오사이언스, 프로바이오틱스 연구 국제학술지 게재…"장 건강...
일동바이오사이언스의 프로바이오틱스 연구 결과가 학술지 게재를 통해 비피도 주식에 긍정적 영향을 미칠 것으로 예상됩니다.
Detailed Momentum
52w lower range (21%)
1m +3.08% (slight rise)
Volume decreasing
Detailed Disclosure
- Neutral합병등종료보고서(자산양수도)2026-08-14
- Neutral반기보고서 (2026.06)2026-08-14
